XCOPRI® (cenobamate tablets) CV For The Treatment of Partial-Onset Seizures in Adults

Jul 28, 2022 12:00pm -
Jul 28, 2022 01:00pm

Event Description

XCOPRI® (cenobamate tablets) CV For The Treatment of Partial-Onset Seizures in Adults

This webinar is sponsored by:
SK life science Announces FDA Clearance of IND Application for its Oncology Candidate, SKL27969, a PRMT5 Inhibitor for the Potential Treatment of Advanced Solid Tumors

Date: Thursday, July 28, 2022
Time: 12:00pm EST

Speaker: Dr. Barry Gidal, PharmaD, University of Wisconsin.
Dr Gidal is a clinical pharmacist at the Epilepsy Center of Excellence at William S Middleton Memorial Veterans Hospital in Madison, Wisconsin. He is also a professor at the School of Pharmacy at the University of Wisconsin-Madison in Madison, Wisconsin.

Description: Join Dr. Barry Gidal, PharmD for a webcast that will look at epilepsy prevalence and treatment options for adults with focal onset seizures. The conversation will also provide an overview of Xcopri, a new anti-seizure medicine indicated for the treatment of adults with focal onset seizure. 

Virtual Platform: GoToWebinar
Target Audience: Healthcare Professionals interested in epilepsy treatments. 


Event Type:Webinar
Category:Webinar
Early registration ends on May 19, 2022.
Regular registration starts on May 20, 2022 and ends on Jul 27, 2022.
Late registration starts on Jul 28, 2022.